Status:
RECRUITING
Ketorolac Levels in Vitreous and Aqueous Samples From Patients Undergoing Combined Cataract and Pars Plana Vitrectomy Surgeries With and Without Intracameral Phenylephrine 1.0% / Ketorolac 0.3%
Lead Sponsor:
DHS Consulting
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This is a clinical trial evaluating Ketorolac levels in vitreous and aqueous humor samples from patients undergoing combined cataract and pars plana vitrectomy surgeries with and without intracameral ...
Detailed Description
Cataract surgery can result in intra- and postoperative inflammation. Various strategies are employed to prevent and combat this inflammatory reaction, including preoperative topical NSAIDs, intraoper...
Eligibility Criteria
Inclusion
- Able to provide informed consent
- Undergoing cataract surgery immediately followed by pars plana vitrectomy
- Diagnosed preoperatively with a structural pathology requiring vitrectomy (e.g., epiretinal membrane, macular hole, and symptomatic vitreous floaters)
- Willing and able to comply with all study procedures
- Male or female, aged ≥ 18 years
Exclusion
- Age \< 18
- Participating in another clinical trial
- Patients undergoing cataract surgery or pars plana vitrectomy alone (not a combined procedure)
- Previous vitrectomy
- Complications at the time of cataract surgery
- A tear in the posterior capsule
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06539637
Start Date
September 1 2023
End Date
February 1 2026
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Consultants of Long Island
Westbury, New York, United States, 11590